483 Roundup: FDA Calls Out Four Firms Over Testing, Sanitation

Drug GMP Report
A A
The FDA issued 483s to five drug manufacturers, taking them to task for quality issues that included sanitation and testing practices.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $200.00